However, the current literature on CCL3L1 in the context of colorectal cancer or chemotherapy-induced peripheral neuropathy is very limited, and no studies have directly compared its role to that of CCL3 in these settings. This evidence concerns the gene CCL3L3 and peripheral neuropathy.